CBx Data Labs Information

There is a need to establish a more significant evidence base on the health outcomes for both new and existing formulas. To date, medical cannabis formulas have not necessarily followed a traditional pharmaceutical development path that includes extensive clinical trials for specific indications. This is why CBx Data Labs is developing software tools to collect and then enable patient data to be better analyzed in market for medical cannabis. Harnessing this type of data through uniquely-designed healthcare applications will go beyond establishing a broad evidence base for specific formulas, but also give both patients and health professionals the ability to better manage the full cycle of care, while also allowing professional organizations, researchers, governments and industry to better understand how a particular course of care is being used in practice.